Arca
Skip to content

True Spinal Fussion System

Orthosis, Spondylolisthesis Spinal Fixation. 510(k) K133690, from Innovative Surgical Designs (Bloomington, IN). Product code MNH, class 2.

As of Nov 17, 2026, K133690 is an FDA 510(k) held by Innovative Surgical Designs, substantially equivalent on May 7, 2014 after 156 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: May 7, 2014
  • Review time: 156 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The True™ Spinal Fixation System is intended for posterior, noncervical (T1-S1) pedicle fixation to provide immobilization and stabilization in skeletally mature patients as an adjunct to fusion for the treatment of the following acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine: severe spondylolisthesis (grades 3 and 4) of the L5-S1 vertebra; degenerative…

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Record

Type
Traditional
Received
Dec 2, 2013
Review panel
Orthopedic
Regulation
21 CFR 888.3070

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.